Glutamate and anxiety disorders (Q36946117)

17 August 2017

1 reference

title

Glutamate and anxiety disorders (English)

1 reference

17 August 2017

Jonathan M Amiel

1

1 reference

PubMed ID

17880858

17 August 2017

Sanjay J Mathew

series ordinal

2

1 reference

PubMed ID

17880858

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Current Psychiatry Reports

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

4

1 reference

17 August 2017

278-283

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-007-0033-7

17 August 2017

0 references

cites work

An open-label study of levetiracetam for the treatment of social anxiety disorder

1 reference

12 December 2020

Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity

1 reference

12 December 2020

An open trial of topiramate in the treatment of generalized social phobia.

1 reference

12 December 2020

Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder

1 reference

12 December 2020

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

1 reference

12 December 2020

Open-label trial of riluzole in generalized anxiety disorder

1 reference

12 December 2020

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

1 reference

12 December 2020

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

1 reference

12 December 2020

Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740.

1 reference

12 December 2020

Structure and trafficking of NMDA and GABAA receptors

1 reference

12 December 2020

Levetiracetam for treatment-refractory posttraumatic stress disorder.

1 reference

12 December 2020

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

12 December 2020

The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory

1 reference

12 December 2020

Panic disorder: treatment with valproate

1 reference

12 December 2020

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

1 reference

12 December 2020

Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder

1 reference

12 December 2020

Seizure activity and off-label use of tiagabine

1 reference

12 December 2020

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

1 reference

12 December 2020

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

12 December 2020

The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study

1 reference

12 December 2020

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder

1 reference

12 December 2020

Azapirones for generalized anxiety disorder

1 reference

12 December 2020

Ionotropic and metabotropic glutamate receptor structure and pharmacology

1 reference

12 December 2020

Regulation of neurotransmitter release by metabotropic glutamate receptors

1 reference

12 December 2020

Anatomy and physiology of glutamate in the CNS.

1 reference

12 December 2020

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

1 reference

12 December 2020

Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing

1 reference

12 December 2020

A double-blind, placebo-controlled study of memantine in the treatment of major depression

1 reference

12 December 2020

Levetiracetam in social phobia: a placebo controlled pilot study

1 reference

12 December 2020

An open-label study of tiagabine as augmentation therapy for anxiety

1 reference

12 December 2020

Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study.

1 reference

12 December 2020

Valproic acid for the treatment of social anxiety disorder

1 reference

12 December 2020

Attitudes toward benzodiazepines over the years

1 reference

12 December 2020

Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy

1 reference

12 December 2020

Placebo-controlled study of gabapentin treatment of panic disorder

1 reference

12 December 2020

Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.

1 reference

12 December 2020

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment

1 reference

12 December 2020

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

12 December 2020

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine

1 reference

12 December 2020

Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.

1 reference

12 December 2020

LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress

1 reference

12 December 2020

10.1007/S11920-007-0033-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17880858